dc.contributor.author |
Zamecnikova, Adriana |
- |
dc.date.accessioned |
2019-12-03T07:28:08Z |
|
dc.date.available |
2019-12-03T07:28:08Z |
|
dc.date.issued |
2019 |
- |
dc.identifier.citation |
Adriana, Zamecnikova. i(3)(q10) in non-Hodgkin's lymphoma (NHL). Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2019, 11, p. 333-335 |
- |
dc.identifier.issn |
1768-3262 |
|
dc.identifier.uri |
http://hdl.handle.net/2042/70608 |
|
dc.description.abstract |
Partial or complete chromosome 3 gains resulting from the presence of trisomy 3, unbalanced translocation or isochromosome formation has been observed in different types of non-Hodgkin's lymphomas (NHL). Among them, the isochromosome of the long arm of chromosome 3 is a relatively rare chromosome aberration, associated mainly with B-cell NHL. However, its occurrence is not restricted to lymphomas, as the detection of +i(3)(q10) is considered a specific marker of polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL) associated with an increase frequency of chromosome 3 instability as well as it may also be found in myeloid malignancies. |
en |
dc.language.iso |
en |
- |
dc.publisher |
ARMGHM - Atlas Génétique des Cancers |
- |
dc.relation |
Atlas of Genetics and Cytogenetics in Oncology and Haematology ; http://AtlasGeneticsOncology.org/Anomalies/i3q10ID2115.html |
- |
dc.relation.ispartofseries |
Atlas of Genetics and Cytogenetics in Oncology and Haematology |
en |
dc.rights |
Open access resource - terms and conditions : http://irevues.inist.fr/utilisation |
- |
dc.subject |
chromosome 3 |
en |
dc.subject |
B-cell lymphomas |
en |
dc.subject |
T-cell lymphomas |
en |
dc.subject.classification |
Leukaemia Section |
en |
dc.subject.mesh |
Antibiotics, Antineoplastic/*pharmacology |
en |
dc.subject.mesh |
Apoptosis/drug effects |
en |
dc.subject.mesh |
Cadherins/*genetics |
en |
dc.subject.mesh |
Carcinogenesis/genetics |
en |
dc.subject.mesh |
Cell Line, Tumor |
en |
dc.subject.mesh |
Cell Survival/drug effects |
en |
dc.subject.mesh |
*DNA Methylation |
en |
dc.subject.mesh |
DNA Modification Methylases/antagonists & inhibitors |
en |
dc.subject.mesh |
Down-Regulation/drug effects |
en |
dc.subject.mesh |
Doxorubicin/*pharmacology |
en |
dc.subject.mesh |
Gene Expression Regulation, Neoplastic/drug effects |
en |
dc.subject.mesh |
Humans |
en |
dc.subject.mesh |
Karyotype |
en |
dc.subject.mesh |
Lymphoma, Non-Hodgkin/*genetics/pathology |
en |
dc.subject.mesh |
Multiple Myeloma/*genetics/pathology |
en |
dc.subject.mesh |
*Promoter Regions, Genetic |
en |
dc.subject.mesh |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
en |
dc.subject.mesh |
Adult |
en |
dc.subject.mesh |
Aged |
en |
dc.subject.mesh |
Aged, 80 and over |
en |
dc.subject.mesh |
Biomarkers, Tumor/genetics/metabolism |
en |
dc.title |
i(3)(q10) in non-Hodgkin's lymphoma (NHL) |
en |
dc.type |
Article |
- |
dc.contributor.affiliation |
Kuwait Cancer Control Center, Kuwait |
- |
dc.identifier.doi |
https://doi.org/10.4267/2042/70608 |
|